Pacira BioSciences PCRX
NASDAQ PCRX
$25.65 +0.26 (+1.02%)
At close: Sep 29, 2026 · 4:00 PM EDT

Pacira BioSciences (PCRX) Current Assets (2010 - 2026)

Updated

Pacira BioSciences' Current Assets was $615.22 million in Q2 2026, down 17.5% from $745.61 million a year earlier but up 19.5% from the prior quarter.

Analysis

Pacira BioSciences (PCRX) Current Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Current Assets at Pacira BioSciences came in at $547.97 million, down 26.5% from FY2024.

  • Current Assets shows a five-year compound annual growth rate of -3.4% (FY2020 to FY2025).
  • In earlier years, Current Assets was $745.13 million in FY2024 (+46.1%), $509.99 million in FY2023 (+2.3%), $498.33 million in FY2022 (-42.5%) and $866.05 million in FY2021 (+32.9%).
  • Quarterly Current Assets has moved between $376.11 million (Q1 2023) and $866.05 million (Q4 2021) over five years.
  • Compared with a year earlier, Current Assets has declined for four straight quarters, with growth averaging 8.0% over the last eight quarters.
  • The best year-over-year quarter for Current Assets over five years was Q3 2024 (growth of 54.3%); the worst was Q1 2023 (a decline of 43.6%).
  • Per Business Quant data, PCRX's Current Assets in the three quarters before Q2 2026 was $514.96 million (Q1 2026), $547.97 million (Q4 2025) and $562.75 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Pacira BioSciences 1.01 Bn 73.12 Mn 148.24 Mn 615.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 615.22 Mn
Mar 31, 2026 514.96 Mn
Dec 31, 2025 547.97 Mn
Sep 30, 2025 562.75 Mn
Jun 30, 2025 745.61 Mn
Mar 31, 2025 759.96 Mn
Dec 31, 2024 745.13 Mn
Sep 30, 2024 689.97 Mn
Jun 30, 2024 632.21 Mn
Mar 31, 2024 543.11 Mn
Dec 31, 2023 509.99 Mn
Sep 30, 2023 447.26 Mn
Jun 30, 2023 429.32 Mn
Mar 31, 2023 376.11 Mn
Dec 31, 2022 498.33 Mn
Sep 30, 2022 533.41 Mn
Jun 30, 2022 526.21 Mn
Mar 31, 2022 667.02 Mn
Dec 31, 2021 866.05 Mn
Sep 30, 2021 822.35 Mn
API Access

Pacira BioSciences Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=PCRX&period=max&api_key=YOUR_API_KEY